October 2020 // Funding

Updated: Nov 6

Synendos Therapeutics has been awarded of an Innosuisse Innovation Grant in collaboration with the group of Prof. J. Gertsch at the University of Bern. The funded project aims to characterize the new drug target of SERIs and to perform other explorative activities on biology and pharmacology of SERIs. The grant (ca. CHF 1m) has a duration of 3 years.



Recent Posts

See All

August 2019 // Funding

Synendos received a co-fund from the European Union as part of the SME Instrument programme (EUR 50’000).

© 2019 Synendos Therapeutics, Inc. All Rights Reserved.

  • LinkedIn - cerchio grigio
  • Twitter - cerchio grigio